Literature DB >> 3527389

Preliminary observations on the use of latex agglutination test for the detection of mastitis due to Streptococcus agalactiae in cows.

R C Daniel, D A Barnum.   

Abstract

A commercial latex agglutination test for the detection of Group B streptococcal antigens was used to detect infection due to Streptococcus agalactiae in whey of bovine milk samples. Fifteen out of 17 known infections were detected, but it was necessary to incubate the wheys at 37 degrees C for 18 hours in nine of the samples. It was found that the latex agglutination test could detect Group streptococcal carbohydrate antigens in whey samples from artificially infected quarters from one to four days after failure to detect the organism on culture or after antibiotic therapy of the affected quarter.

Entities:  

Mesh:

Year:  1986        PMID: 3527389      PMCID: PMC1255176     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  4 in total

1.  Factors associated with the occurrence, cause and outcome of clinical mastitis in dairy cattle.

Authors:  J K Pearson; D P Mackie
Journal:  Vet Rec       Date:  1979-11-17       Impact factor: 2.695

2.  Commercial latex agglutination for detection of group B streptococcal antigen in body fluids.

Authors:  C J Baker; M A Rench
Journal:  J Pediatr       Date:  1983-03       Impact factor: 4.406

3.  The use of polyethylene intramammary device in protection of the lactating bovine udder against experimental infection with Staphylococcus aureus or Streptococcus agalactiae.

Authors:  B W Brooks; D A Barnum
Journal:  Can J Comp Med       Date:  1982-07

4.  A survey of clinical mastitis in South-East Queensland dairy herds.

Authors:  R C Daniel; D O'Boyle; M S Marek; A J Frost
Journal:  Aust Vet J       Date:  1982-04       Impact factor: 1.281

  4 in total
  1 in total

1.  Specific detection by PCR of Streptococcus agalactiae in milk.

Authors:  G Martinez; J Harel; M Gottschalk
Journal:  Can J Vet Res       Date:  2001-01       Impact factor: 1.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.